Results 51 to 60 of about 5,253,073 (166)

Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma by Targeting the Epidermal Growth Factor Receptor Combined with Gemcitabine Plus Platinum

open access: yesCancer Management and Research, 2020
Chen Chen,1,2,* Xuanye Zhang,2,3,* Yixin Zhou,2,4,* Sha Fu,5 Zuan Lin,2,6 Shaodong Hong,2,3 Li Zhang2,3 1Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People’s Republic of China; 2State Key Laboratory
Chen C   +6 more
doaj  

Oral capecitabine in gemcitabine-pretreated patients with advanced pancreatic cancer [PDF]

open access: yes, 2007
Objective: To date, no standard regimen for salvage chemotherapy after gemcitabine (Gem) failure has been defined for patients with advanced pancreatic cancer (PC). Oral capecitabine (Cap) has shown promising activity in first-line chemotherapy trials in
Haas, Michael   +19 more
core   +1 more source

Prognostic awareness and prognostic information preferences among advanced cancer patients in Kenya

open access: yesAfrican Journal of Primary Health Care & Family Medicine
Background: Cancer is the third leading cause of death in Kenya. Yet, little is known about prognostic awareness and preferences for prognostic information.
Hussein Elias   +4 more
doaj   +1 more source

Cancer Trends: Cervical cancer

open access: yes, 2017
In the period 2013-2015, invasive cancer of the cervix uteri (ICD10: C53) accounted for just over 1% of all invasive cancers (excluding non-melanoma skin cancer) in Ireland, with an average of 262 cases diagnosed per year.
National Cancer Registry Ireland (NCRI)
core  

Status quo and related factors analysis of cognition and attitude toward death with dignity in patients with advanced cancer

open access: yesHuli yanjiu, 2020
ObjectiveTo understand the cognition and attitude toward death with dignity in patients with advanced cancer,and to analyze the influencing factors.MethodsA total of 177 patients with advanced cancer,who were in hospital in Tianjin Medical University ...
QUAN Manman   +3 more
doaj  

Cancer Trends: Cancer of unknown primary

open access: yes, 2019
Between 2012 and 2016, over 450 patients per year were diagnosed with a malignant cancer where the primary site of their cancer was unspecified. These cancers were identified by the presence of metastatic disease where the cancer has spread to other ...
National Cancer Registry Ireland (NCRI)
core  

Cancer Trends: Breast cancer 1994-2016

open access: yes, 2019
There were 62,052 cases of newly diagnosed invasive or in situ breast tumours registered in Ireland by the National Cancer Registry for the period 1994–2016, of which 56,366 were invasive (ICD10: C50) and 5,686 were carcinoma in situ (ICD10: D05 ...
National Cancer Registry Ireland (NCRI)
core  

Practice Patterns of Palliative Radiotherapy for Advanced Cancer at a Large Institute in Saudi Arabia

open access: yesPalliative Medicine Reports
Background and Aims: Palliative radiotherapy practice patterns have been reported to vary widely, with a notable underutilization of single fraction treatment schedules.
Wsam Ghandourh   +4 more
doaj   +1 more source

Relevance of Patient-Reported Outcome Measures in Patients with Cancer: Detection of Underrated Psychological Distress of Palliative Care Patients in an Outpatient Setting

open access: yesPalliative Medicine Reports
Background: The overall level of physical and psychological symptom burden of advanced cancer patients (ACP) in an outpatient setting is notoriously difficult to assess.
Madeleine Fink   +7 more
doaj   +1 more source

Advances in Cancer Pain [PDF]

open access: yesArchives of Neurology, 1999
Advances in cancer pain research and management are an example of the advances that have occurred within the field of neuro-oncology, the medical discipline that includes the diagnosis and treatment of primary central nervous system neoplasms, metastatic and nonmetastatic neurological complications of cancer originating outside the nervous system, and ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy